Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio

Ultra Nasdaq Biotechnology 2X ETF (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

ETF Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	BIB
Company	Ultra Nasdaq Biotechnology 2X ETF
Price Information
Exchange	NASDAQ
Open	53.31
High	53.31
Low	52.36
Last	53.29
Change	+0.71
% Change	+1.34%
Volume	5,195
20-Day Average Volume	23,503
Previous Close	52.58
Industry	N/A
Has Options	Yes
Technicals
20-Day Moving Average	51.01
20-Day Raw Stochastic	73.32%
20-Day Relative Strength	49.59%
Weighted Alpha	-5.20
Today's Opinion	8% Sell
Previous Opinion	8% Sell
Last Month's Opinion	24% Buy
Performance
5-Days
%Chg	+7.89% since 04/25/24
Low	48.83 on 04/26/24
High	53.70 on 05/01/24
1-Month
%Chg	-2.87% since 04/02/24
Low	47.19 on 04/19/24
High	55.46 on 04/04/24
3-Month
%Chg	-7.47% since 02/02/24
Low	47.19 on 04/19/24
High	62.45 on 02/27/24
6-Month
%Chg	+20.47% since 11/02/23
Low	40.54 on 11/10/23
High	62.45 on 02/27/24
Key Statistics
Market Capitalization, $K	85,705
Shares Outstanding, K	1,630
Annual Sales	0
Annual Net Income	0
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	1.63
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	06/27/14
Most Recent Dividend	0.040 on 03/20/24
Next Ex-Dividends Date	03/20/24
Ratios
Price/Earnings ttm	0.00